Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?

Clinical Infectious Diseases

Volumn 34, Issue 5, 2002, Pages 634-640

  Livermore, David M ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMIKACIN ACETYLTRANSFERASE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZLOCILLIN; AZTREONAM; BETA LACTAMASE; CARBAPENEMASE; CARBENICILLIN; CEFEPIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); ENZYME; GENTAMICIN; IMIPENEM; INTEGRIN; MEROPENEM; PIPERACILLIN; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ENTEROBACTER; GENE MUTATION; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; GENE FREQUENCY; HUMANS; INTEGRINS; MICROBIAL SENSITIVITY TESTS; MULTIGENE FAMILY; MUTATION; PSEUDOMONAS AERUGINOSA;

EID: 0036498656     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/338782     Document Type: Article

References (29)

1. β-Lactamases in laboratory and clinical resistance
2. Properties of the large ion-permeable pores formed from protein F of Pseudomonas aeruginosa in lipid bilayer membranes
3. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms
4. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa
5. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa
6. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa
7. Construction and characterization of Pseudomonas aeruginosa protein F-deficient mutants after in vitro and in vivo insertion mutagenesis of the cloned gene
8. Review of epidemic aminoglycoside resistance worldwide
9. Selective imipenem resistance in Pseudomonas aeruginosa associated with diminished outer membrane permeability
10. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids
11. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance
12. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
13. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: A nationwide multicenter study
14. OXA-type β-lactamases
15. OXA-28, an extended-spectrum variant of OXA-10 β-lactamase from Pseudomonas aeruginosa and its plasmid- and integrin-located gene
16. OXA-17, a further extended-spectrum variant of OXA-10 β-lactamase, isolated from Pseudomonas aeruginosa
17. Carbapenemases: A problem in waiting?
18. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems
19. IMP-7
20. VIM, a new integrin-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate
21. IMP
22. Antimicrobial susceptibility, of Pseudomonas aeruginosa: Results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test
23. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program
24. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece
25. Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents
26. Of Pseudomonas, porins, pumps and carbapenems
27. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
28. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy
29. Inhibition of IMP-1 metallo-β-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives